Net earnings for the second quarter were reported as $165.5 million non-adjusted and $221.2 million on an adjusted basis, which is a 2.6 percent increase when adjusted over last year’s report. The diluted earnings for the quarter were reported as $0.82 per share on net sales of $1.06 billion. Zimmer board of directors approved an additional $1.5 billion stock repurchase program.
The company also announced their agreement to acquire Beigin Montagne Medical Device, an orthopedic implant company based in China.
Read the Zimmer Holdings release on 2010 2Q financial results.
Read other coverage on Zimmer Holdings.
-Zimmer Names New President of Global Business
-Zimmer Launces Cephalomedullary Nail System
-Simmer Net Sales Grow 7.5 Percent
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
